Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 205 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Enrollment reopened
    • Lead sponsor: Children's Oncology Group to Children's Oncology Group
    • Site details revised at 164 of 164 sites
    • Eligibility criteria expanded, about 3 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 164 of 164 sites
    v204
  3. Re-verified, no change to tracked fieldsv203
  4. Start date: May 19, 2008 to Jul 17, 2008
    • Enrollment target: 4738 to 5000
    • Study description expanded, about 11 words
    v202
  5. Study description expanded, about 4 wordsv201
Show 45 earlier versionsHide 45 earlier versions
  1. Eligibility criteria shortened, about 130 wordsv200
  2. 2 versions Re-verified since Sep 3, 2021, no change to tracked fieldsv198-v199
  3. Eligibility criteria shortened, about 127 words
    • Study description shortened, about 18 words
    v197
  4. Re-verified, no change to tracked fieldsv196
  5. Study sites revised (164)v195
  6. Study sites: 167 to 164v194
  7. Enrollment target: 4485 to 4738v193 Show 5 more changesShow less
    • Study sites: 162 to 167
    • Primary completion date: Jan 2100 to Jan 31, 2100
    • Start date: May 2008 to May 19, 2008
    • Eligibility criteria expanded, about 12 words
    • Study description shortened, about 21 words
  8. 2 versions Re-verified since Oct 14, 2016, no change to tracked fieldsv191-v192
  9. Enrollment target: 7500 to 4485
    • Study sites: 156 to 162
    • Eligibility criteria shortened, about 7 words
    v190
  10. Re-verified, no change to tracked fieldsv189
  11. Enrollment target: 906 to 7500v188 Show 5 more changesShow less
    • Primary endpoints revised (6)
    • Study sites: 136 to 156
    • Interventions: assessment of therapy complications (Procedure), long-term screening (Procedure), study of high risk factors (Procedure), survey… to Assessment of Therapy Complications (Procedure), Questionnaire Administration (Other)
    • Eligibility criteria expanded, about 221 words
    • Study description expanded, about 5 words
  12. Re-verified, no change to tracked fieldsv187
  13. Site contacts updated at 1 of 136 sitesv186
  14. Primary completion date: Feb 2008 to Jan 2100v185 Show 5 more changesShow less
    • Start date: May 2007 to May 2008
    • Study sites: 113 to 136
    • Eligibility criteria shortened, about 9 words
    • Study description expanded, about 6 words
    • Study arms: 0 to 1
  15. Study sites: 112 to 113v184
  16. Site contacts updated at 1 of 112 sitesv183
  17. Re-verified, no change to tracked fieldsv182
  18. Study sites: 111 to 112v181
  19. Study sites: 110 to 111v180
  20. Site contacts updated at 1 of 110 sitesv179
  21. Study sites: 109 to 110v178
  22. Study sites: 108 to 109v177
  23. Re-verified, no change to tracked fieldsv176
  24. Study sites: 107 to 108v175
  25. Study sites revised (107)v174
  26. Re-verified, no change to tracked fieldsv173
  27. Study sites: 106 to 107v172
  28. Site contacts updated at 1 of 106 sitesv171
  29. Re-verified, no change to tracked fieldsv170
  30. Study sites: 105 to 106v169
  31. Study sites: 104 to 105v168
  32. Study sites: 103 to 104v167
  33. Study sites revised (103)v166
  34. Re-verified, no change to tracked fieldsv165
  35. Study sites: 102 to 103v164
  36. Study sites: 88 to 102v163
  37. Study sites revised (88)v162
  38. 2 versions Re-verified since Sep 2, 2010, no change to tracked fieldsv160-v161
  39. Study sites: 89 to 88v159
  40. Study sites: 90 to 89v158
  41. Site contacts updated at 1 of 90 sitesv157
  42. Site contacts updated at 1 of 90 sitesv156
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Trial Details
NCT Number NCT00736749
Lead Sponsor Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Hematopoietic Cell Transplantation Recipient, Leukemia, Solid Tumor
Related terms Leukemia
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Updated on ClinicalTrials.gov